Low-risk Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Low-risk Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial evaluating bemcentinib for myelodysplastic syndromes and related conditions has completed.